1. Home
  2. SUPN vs MAN Comparison

SUPN vs MAN Comparison

Compare SUPN & MAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

HOLD

Current Price

$47.64

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Logo ManpowerGroup

MAN

ManpowerGroup

HOLD

Current Price

$56.60

Market Cap

2.4B

ML Signal

HOLD

Company Overview

Basic Information
Metric
SUPN
MAN
Founded
2005
1948
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Professional Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.4B
IPO Year
2010
1994

Fundamental Metrics

Financial Performance
Metric
SUPN
MAN
Price
$47.64
$56.60
Analyst Decision
Strong Buy
Hold
Analyst Count
5
6
Target Price
$61.60
$35.67
AVG Volume (30 Days)
958.1K
1.5M
Earning Date
05-05-2026
04-16-2026
Dividend Yield
N/A
4.69%
EPS Growth
N/A
N/A
EPS
N/A
0.05
Revenue
$392,755,000.00
$17,957,100,000.00
Revenue This Year
$22.70
$5.12
Revenue Next Year
$19.14
$3.42
P/E Ratio
N/A
$1,106.80
Revenue Growth
N/A
0.58
52 Week Low
$40.32
$25.15
52 Week High
$59.68
$57.08

Technical Indicators

Market Signals
Indicator
SUPN
MAN
Relative Strength Index (RSI) 50.78 69.02
Support Level $43.43 $27.11
Resistance Level $47.55 $56.39
Average True Range (ATR) 2.49 2.33
MACD -0.13 -0.19
Stochastic Oscillator 41.87 78.78

Price Performance

Historical Comparison
SUPN
MAN

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, Osmolex ER, and others.

About MAN ManpowerGroup

ManpowerGroup Inc provides workforce solutions and services, including recruitment and assessment, upskilling, reskilling, training and development, career management, outsourcing, and workforce consulting. The company leverages its trusted brands, industry knowledge, and AI-enabled assessments and offers an extensive portfolio of training and leadership development solutions. Its reportable segments are Staffing and Interim, Outcome-Based Solutions and Consulting, Permanent Recruitment, and Others, with Staffing and Interim generating the majority of revenue. It operates in the Americas, Southern Europe, Northern Europe, and APME. The company derives the maximum geographical revenue from the Southern European region.

Share on Social Networks: